Apple reportedly tests Chinese DRAM after supplier CXMT holds the line on pricing

Apple is reportedly testing Chinese DRAM from Semiconductor Manufacturing International Corporation’s memory arm, CXMT, according to a market report published Tuesday. The testing is described as part of efforts to qualify alternative memory sources for multiple Apple product lines, including iPhones and MacBooks.

The report ties Apple’s move to pricing negotiations with CXMT. It says CXMT refused to cut prices to the level Apple wanted, a point that did not stop Apple from continuing to evaluate the supplier’s memory chips. In other words, the company’s willingness to test the technology appears to be separate from agreeing on pricing terms.

DRAM, or dynamic random access memory, is the high-speed working memory that devices use to hold active data while applications and the operating system run. Because Apple’s iPhone and Mac product refresh cycles rely on scale sourcing and tight component cost management, memory pricing and supply stability can materially affect overall bill-of-materials costs.

The market report characterizes Apple’s DRAM tests as covering more than a single device category, implying that Apple could be assessing whether CXMT’s chips can perform well enough and clear internal qualification hurdles for broader use. However, the report does not specify which exact memory speeds, capacities, or packaging formats are being evaluated.

Neither Apple nor CXMT provided accompanying public commentary in the report. The posting also does not disclose whether Apple is testing in production-like conditions, the timelines involved, or the likelihood that any CXMT-based DRAM would appear in consumer devices.

Separately, Apple has an extensive track record of testing components and diversifying suppliers to manage operational and geopolitical risk. In this context, memory qualification can be both technical and commercial, since vendors must satisfy performance targets as well as long-term pricing and availability expectations.

There is also an open question about what “testing” means in practical terms. Component qualification can range from early validation prototypes to longer-cycle reliability testing, and the report does not spell out where Apple is in that process. Without those details, it is not possible to determine whether the effort is exploratory or close to any hardware rollout.

What to watch next is whether Apple updates its supplier and production posture through public channels such as regulatory disclosures, earnings commentary, or official announcements around supply-chain readiness. The next datapoint could also come from independent reporting that identifies additional device models and the timing of any DRAM sourcing changes.